1
|
Velidakis N, Khattab E, Gkougkoudi E, Kadoglou NPE. Pulmonary Hypertension in Left Ventricular Valvular Diseases: A Comprehensive Review on Pathophysiology and Prognostic Value. Life (Basel) 2023; 13:1793. [PMID: 37763197 PMCID: PMC10532440 DOI: 10.3390/life13091793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2023] [Revised: 08/14/2023] [Accepted: 08/18/2023] [Indexed: 09/29/2023] Open
Abstract
Left ventricular (LV) valvular diseases, make up one of the most common etiologies for pulmonary hypertension (PH), and it is not well understood how and at which degree it affects prognosis. The aim of the present study was a comprehensive review of the pathophysiologic mechanism of PH in patients with LV valvular diseases and the prognostic value of baseline and post-intervention PH in patients undergoing interventional treatment. The pathophysiology of PH in patients with LV valvular diseases involves gradual elevation of left ventricular filling pressure and left atrial pressure, which are passively transmitted to the pulmonary circulation and raise pulmonary artery systolic pressure (PASP). A long-lasting exposure to elevated PASP progressively leads to initially functional and thereafter irreversible structural changes in the pulmonary vasculature, leading up to high pulmonary vascular resistance. Surgical treatment of severe LV valvular diseases is highly effective in patients without resting PH or those with exercise-induced PH (EIPH) before intervention. In the case of pre-operative PH, successful interventional therapy decreases PASP, but the post-operative cardiac and all-cause mortality remain higher compared to patients without pre-operative PH. Hence, it is of paramount importance to detect patients with severe LV valvulopathies before the development of PH, since they will get greater benefits from early intervention.
Collapse
Affiliation(s)
| | | | | | - Nikolaos P. E. Kadoglou
- Medical School, University of Cyprus, Palaios Dromos Lefkosias Lemesou No. 215/62029 Aglantzia, P.O. Box 20537 1678, Nicosia 2024, Cyprus
| |
Collapse
|
2
|
Genuardi MV, Shpilsky D, Handen A, VanSpeybroeck G, Canterbury A, Lu M, Shapero K, Nieves RA, Thoma F, Mulukutla SR, Cavalcante JL, Chan SY. Increased Mortality in Patients With Preoperative and Persistent Postoperative Pulmonary Hypertension Undergoing Mitral Valve Surgery for Mitral Regurgitation: A Cohort Study. J Am Heart Assoc 2021; 10:e018394. [PMID: 33599144 PMCID: PMC8174242 DOI: 10.1161/jaha.120.018394] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Background Preoperative pulmonary hypertension (PH) is associated with excess mortality among patients with severe mitral regurgitation undergoing mitral valve surgery (MVS). However, the links between PH phenotype, pulmonary vascular remodeling, and persistent postoperative PH are not well understood. We aimed to describe the associations between components of pulmonary hemodynamics as well as postoperative residual PH with longitudinal mortality in patients with severe mitral regurgitation who received MVS. Methods and Results Patients undergoing MVS for severe mitral regurgitation from 2011 to 2016 were retrospectively identified within our health system (n=488). Mean pulmonary artery pressure and other hemodynamic variables were determined by presurgical right-heart catheterization. Postoperative pulmonary artery systolic pressure was assessed on echocardiogram 42 to 365 days post-MVS. Longitudinal survival over a mean 3.9 years of follow-up was evaluated using Cox proportional hazards modeling to compare survival after adjustment for demographics, surgical characteristics, and comorbidities. Pre-MVS prevalence of PH was high at 85%. After adjustment, each 10-mm Hg increase in preoperative mean pulmonary artery pressure was associated with a 1.38-fold increase in risk of death (95% CI, 1.13-1.68). Elevated preoperative pulmonary vascular resistance, transpulmonary gradient, and right atrial pressure were similarly associated with increased mortality. Among 231 patients with postoperative echocardiogram, evidence of PH on echocardiogram (pulmonary artery systolic pressure ≥35 mm Hg) was associated with increased risk of death (hazard ratio [HR], 2.02 [95% CI, 1.17-3.47]); however, this was no longer statistically significant after adjustment (HR, 1.55 [95% CI, 0.85-2.85]). Conclusions In patients undergoing MVS for mitral regurgitation, preoperative PH, and postoperative PH were associated with increased mortality.
Collapse
Affiliation(s)
- Michael V Genuardi
- Center for Pulmonary Vascular Biology and Medicine Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute Pittsburgh PA.,Division of Cardiology Perelman School of Medicine, University of Pennsylvania Philadelphia PA
| | - Daniel Shpilsky
- Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| | - Adam Handen
- Center for Pulmonary Vascular Biology and Medicine Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute Pittsburgh PA
| | | | - Ann Canterbury
- Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| | - Michael Lu
- Department of Medicine University of Pittsburgh School of Medicine Pittsburgh PA
| | - Kayle Shapero
- Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| | - Ricardo A Nieves
- Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| | - Floyd Thoma
- Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| | - Suresh R Mulukutla
- Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| | - João L Cavalcante
- Cardiovascular Imaging Center Minneapolis Heart InstituteAbbott Northwestern Hospital Minneapolis MN
| | - Stephen Y Chan
- Center for Pulmonary Vascular Biology and Medicine Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute Pittsburgh PA.,Division of Cardiology University of Pittsburgh School of Medicine Pittsburgh PA
| |
Collapse
|
3
|
Go YY, Dulgheru R, Sugimoto T, Marchetta S, Oury C, Lancellotti P. Exercise Doppler echocardiography for the diagnosis of pulmonary hypertension: renewed interest and evolving roles. J Thorac Dis 2017; 9:2856-2861. [PMID: 29221256 DOI: 10.21037/jtd.2017.08.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Yun Yun Go
- Department of Cardiology, National Heart Centre Singapore, Singapore.,Departments of Cardiology, Heart Valve Clinic, University of Liège Hospital, University Hospital Sart Tilman, Liège, Belgium
| | - Raluca Dulgheru
- Departments of Cardiology, Heart Valve Clinic, University of Liège Hospital, University Hospital Sart Tilman, Liège, Belgium
| | - Tadafumi Sugimoto
- Departments of Cardiology, Heart Valve Clinic, University of Liège Hospital, University Hospital Sart Tilman, Liège, Belgium
| | - Stella Marchetta
- Departments of Cardiology, Heart Valve Clinic, University of Liège Hospital, University Hospital Sart Tilman, Liège, Belgium
| | - Cécile Oury
- GIGA Cardiovascular Sciences, University Hospital Sart Tilman, Liège, Belgium
| | - Patrizio Lancellotti
- Departments of Cardiology, Heart Valve Clinic, University of Liège Hospital, University Hospital Sart Tilman, Liège, Belgium.,GIGA Cardiovascular Sciences, University Hospital Sart Tilman, Liège, Belgium.,Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy
| |
Collapse
|
4
|
Lancellotti P, Dulgheru R, Go YY, Sugimoto T, Marchetta S, Oury C, Garbi M. Stress echocardiography in patients with native valvular heart disease. Heart 2017; 104:807-813. [DOI: 10.1136/heartjnl-2017-311682] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2017] [Revised: 10/30/2017] [Accepted: 11/15/2017] [Indexed: 12/20/2022] Open
Abstract
Valve stress echocardiography (VSE) can be performed as exercise stress echocardiography (ESE) or dobutamine stress echocardiography (DSE) depending on the patient’s clinical status, severity and type of valve disease. ESE combines exercise testing with two-dimensional grey scale and Doppler echocardiography during exercise. Thus, it provides objective assessment of symptomatic status (exercise test), as well as exercise-induced changes of a series of echocardiographic parameters (different depending on the valve disease type), which yield prognostic information in individual patients and help in a better treatment planning. DSE is useful in symptomatic patients with low-gradient aortic stenosis. It clarifies its severity and helps in assessing surgical risk in patients with severe disease and systolic dysfunction. It can be also used to test valve haemodynamics in asymptomatic patients with significant mitral stenosis unable to perform an exercise test or to test the left ventricle response, namely to test viability, in patients with ischaemic secondary mitral regurgitation. VSE has taught us that history taking, clinical examination and resting echocardiography give an ‘incomplete picture’ of the disease in patients presenting with a severe valve disease. Therefore, its use should be encouraged in such patients.
Collapse
|
5
|
Lancellotti P, Radermecker M, Durieux R, Modine T, Oury C, Fattouch K. Transapical beating-heart chordae implantation in mitral regurgitation: a new horizon for repairing mitral valve prolapse. J Thorac Dis 2016; 8:E1665-E1671. [PMID: 28149609 DOI: 10.21037/jtd.2016.12.78] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Patrizio Lancellotti
- Department of Cardiology, GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, University Hospital Sart Tilman, Liège, Belgium; ; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy
| | - Marc Radermecker
- Department of Cardiovascular Surgery, University of Liège Hospital, GIGA Cardiovascular Sciences, University Hospital Sart Tilman, Liège, Belgium; ; Department of human anatomy, University of Liège, Belgium
| | - Rodolphe Durieux
- Department of Cardiovascular Surgery, University of Liège Hospital, GIGA Cardiovascular Sciences, University Hospital Sart Tilman, Liège, Belgium
| | - Thomas Modine
- Department of Cardiovascular Surgery, CHRU de Lille, France
| | - Cécile Oury
- Department of Cardiology, GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, University Hospital Sart Tilman, Liège, Belgium
| | - Khalil Fattouch
- Cardiovascular Department, GVM Care and Research, Maria Eleonora Hospital, Palermo, Italy; ; Department of Surgery and Cancer, University of Palermo, Palermo, Italy
| |
Collapse
|
6
|
Martinez C, Bernard A, Dulgheru R, Incarnato P, Oury C, Lancellotti P. Pulmonary Hypertension in Aortic Stenosis and Mitral Regurgitation: Rest and Exercise Echocardiography Significance. Prog Cardiovasc Dis 2016; 59:59-70. [PMID: 27389810 DOI: 10.1016/j.pcad.2016.06.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Accepted: 06/29/2016] [Indexed: 01/21/2023]
Abstract
Valvular heart disease is a common cause of increased mean pulmonary artery pressure (PAP). Aortic stenosis and mitral regurgitation are frequently accompanied by pulmonary hypertension (PH), especially when they are severe and symptomatic. In asymptomatic patients, PH is rare, though the exact prevalence is unknown and mainly stems from the severity of the valvular heart disease and the presence of diastolic dysfunction. Exercise echocardiography has recently gained interest in depicting PH. In these asymptomatic patients, exercise PH is observed in about >40%. Either PH at rest (systolic PAP >50 mmHg) or during exercise (systolic PAP >60 mmHg) is a powerful determinant of outcome and is independently associated with reduced survival, regardless of the severity of the underlying valvular pathology.
Collapse
Affiliation(s)
- Christophe Martinez
- University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium
| | - Anne Bernard
- University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; University of Tours Hospital, Cardiology Department, Tours, France and University François Rabelais, Tours, France
| | - Raluca Dulgheru
- University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium
| | - Pierluigi Incarnato
- University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium
| | - Cécile Oury
- University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium
| | - Patrizio Lancellotti
- University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.
| |
Collapse
|